Latest News

Media Release – Kiwis with MS ‘light years’ behind Aussie patients in treatment access and quality of life – study.

September 14, 2021 | Advocacy, Media, Study, Uncategorised

Media Release: 14 September 2021 (For Immediate Release) A new trans-Tasman study has highlighted alarming health inequities between New Zealand patients living with multiple sclerosis (MS) and their Australian counterparts — adding fuel to the ongoing fight for Pharmac to […]


New Clinical Trial for those with Primary Progressive MS – Now recruiting

June 14, 2021 | Advocacy, Treatments, Trials

About 10% of people with MS are diagnosed with Primary Progressive Multiple Sclerosis (PPMS). While more common forms of MS involve a relapse-remit pattern (unpredictable attacks followed by periods of disease inactivity), PPMS is characterised by a slow onset and […]


MSNZ President receives Queen’s birthday Honour

June 8, 2021 | Advocacy, Media

Multiple Sclerosis NZ is thrilled to announce our President, Neil Woodhams, has received an honour in the Queen’s Birthday List for recognition of his services to people with Multiple Sclerosis. Neil is a leading advocate for New Zealanders with MS, […]


Covid Vaccine update for People with MS & Webinar

June 3, 2021 | Advocacy, Covid-19, Event, Treatments, Uncategorised

Understandably, there is a high level of interest within the Multiple Sclerosis (MS) Community for information about how the Pfizer vaccine works and is impacting people with MS globally. Due to this Multiple Sclerosis New Zealand and the Ministry of […]


Special Authority Criteria Amendment for DMTs

May 26, 2021 | Advocacy

Multiple Sclerosis NZ received several reports from concerned patients regarding the ambiguity of the Special Authority Criteria for DMTs. With the support of Dr John Mottershead, Pharmac were approached for clarification. Concern centred around whether bilateral aids qualify for use […]